Immunization, Hib3 (% of children ages 12-23 months) in North Korea
North Korea: Immunization, Hib3 (% of children ages 12-23 months) was 99.0% in 2024. ▲ Rising
Immunization, Hib3 in North Korea, 2012–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
North Korea recorded 99.0% for immunization, hib3 in 2024. That is the highest value across all 13 years on record.
That represents a change of up 6.5% over ten years.
Over the whole period, immunization, hib3 in North Korea peaked at 99.0% in 2021 and was at its lowest, 32.0%, in 2012.
North Korea ranks 1st of 191 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 13 years of available data.
Immunization, Hib3 (% of children ages 12-23 months) in North Korea, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2012 | 32.0% | — |
| 2013 | 93.0% | +190.6% |
| 2014 | 93.0% | +0.0% |
| 2015 | 96.0% | +3.2% |
| 2016 | 96.0% | +0.0% |
| 2017 | 97.0% | +1.0% |
| 2018 | 97.0% | +0.0% |
| 2019 | 97.0% | +0.0% |
| 2020 | 97.0% | +0.0% |
| 2021 | 99.0% | +2.1% |
| 2022 | 99.0% | +0.0% |
| 2023 | 99.0% | +0.0% |
| 2024 | 99.0% | +0.0% |
North Korea compared with similar countries
- North Korea's 99.0% is above the median for low income countries, which is 73.0%, 1.4× the median. (25 countries reporting)
- North Korea's 99.0% is above the median for East Asia & Pacific, which is 93.0%, 1.1× the median. (29 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 87.6% | 32.0% | 97.0% | 8 |
| 2020s | 98.6% | 97.0% | 99.0% | 5 |
Countries ranked near North Korea
- 1 Antigua and Barbuda 99.0% compare
- 1 Brunei 99.0% compare
- 1 Costa Rica 99.0% compare
- 1 Cuba 99.0% compare
- 1 Greece 99.0% compare
- 1 Hungary 99.0% compare
- 1 Jamaica 99.0% compare
- 1 Kuwait 99.0% compare
- 1 Luxembourg 99.0% compare
- 1 Maldives 99.0% compare
- 1 Monaco 99.0% compare
- 1 Oman 99.0% compare
- 1 Palau 99.0% compare
- 1 Portugal 99.0% compare
- 1 Saint Lucia 99.0% compare
- 1 Saint Vincent and the Grenadines 99.0% compare
- 1 Tonga 99.0% compare
- 1 Turkey 99.0% compare
More health data for North Korea
- Un projection of annual infant deaths 767 (2100)
- Un projection of annual infant deaths, annual growth rate -1.16 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2456 % change on previous year (2090)
- Diphtheria - number of reported cases, gaps filled 0 (2022)
- Measles - number of reported cases, gaps filled 0 (2025)
- Diphtheria - number of reported cases, per capita 0 units per person (2022)
- Population ages 15-64, total, annual growth rate -0.1528 % change on previous year (2025)
- Population ages 15-64, total, per capita 0.6836 units per person (2025)
- Population ages 65 and above, female, per capita 0.073 units per person (2025)
- Pertussis - number of reported cases, per capita 0 units per person (2022)
Frequently asked questions
- What is immunization, hib3 in North Korea?
- Immunization, hib3 in North Korea was 99.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in North Korea?
- The highest recorded value was 99.0% in 2021.
- What is the lowest immunization, hib3 recorded in North Korea?
- The lowest recorded value was 32.0% in 2012.
- How does North Korea rank for immunization, hib3?
- North Korea ranks 1st out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in North Korea?
- Over the last ten years it is up 6.5%. The long-run trend across the full record is rising.
- Where does this North Korea data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 13 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.